Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1
Plasminogen deficiency type 1 (PLGD-1, hypoplasminogenemia) is an ultra-rare, lifelong disease associated with development of fibrinous lesions in multiple organ systems. Depending on lesion location, clinical manifestations of PLGD-1 can result in acute and/or chronic respiratory airway disease whi...
Saved in:
Main Authors: | Charles Nakar (Author), Heather McDaniel (Author), Joseph M. Parker (Author), Karen Thibaudeau (Author), Neelam Thukral (Author), Amy D. Shapiro (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions
by: Carla Samily de Oliveira Costa, et al.
Published: (2022) -
Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022) -
The Role of the Plasminogen Activating System in Neurobiology
by: Robert L. Medcalf
Published: (2017) -
Thrombus attached to suture materials successfully thrombolysed with low-dose tissue plasminogen activator
by: Macit Kalçık, et al.
Published: (2014) -
Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
by: Kiyofumi Yamada, et al.
Published: (2005)